References
Linker-Israeli M, Wallace DJ, Prehn J, Michael D, Honda M, Taylor KD, Paul-Labrador M, Fischel-Ghodsian N, Fraser PA, Klinenberg JR (1999) Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes Immun 1(1):45–52
Hrycek A, Siekiera U, Cieélik P, Szkróbka W (2005) HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus. Rheumatol Int 26(1):1–6
Guarnizo-Zuccardi P, Lopez Y, Giraldo M, Garcia N, Rodriguez L, Ramirez L, Uribe O, Garcia L, Vasquez G (2007) Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 70(5):376–382
Chua KH, Kee BP, Tan SY, Lian LH (2009) Interleukin-6 promoter polymorphisms (−174G/C) in Malaysian patients with systemic lupus erythematosus. Braz J Med Biol Res 42(2):551–555
Schotte H, Schlüter B, Rust S, Assmann G, Domschke W, Gaubitz M (2001) Interleukin-6 promoter polymorphisms (−174G/C) in Caucasian German with systemic lupus erythematosus. Rheumatology 40(4):393–400
Godarzi EM, Sarvestani EK, Aflaki E, Amirghofran Z (2011) Interleukin-6 gene polymorphism in Iranian patients with systemic lupus erythematosus. Clin Rheumatol 30(2):179–184
Santos MJ, Santos D, Capela S, da Silva JC, Fonseca JE (2011) Interleukin-6 promoter polymorphism −174G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients. Clin Rheumatol 30(3):409–413
Bernatsky S, Peschken C, Fortin PR, Pineau CA, Urowitz MB, Gladman DD, Pope JE, Hudson M, Zummer M, Smith CD, Arbillaga HO, Clarke AE (2011) Medication use in systemic lupus erythematosus. J Rheumatol 38(2):271–274
Isenberg D, Appel GB, Contreras G, Dooley MA, Ginzler EM, Jayne D, Sánchez-Guerrero J, Wofsy D, Yu X, Solomons N (2010) Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology 49(1):128–140
Lee HS, Bae SC (2010) What can we learn from genetic studies of systemic lupus erythematosus? Implications of genetic heterogeneity among populations in SLE. Lupus 19(12):1452–1459
Acknowledgment
This work was partly supported by grants from the key program of National Natural Science Foundation of China (30830089) and the Anhui Provincial Natural Science Foundation (11040606M183).
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Xu, WD., Zhang, YJ., Pan, HF. et al. Targeting IL-6 promoter polymorphism −174G/C should be dependent on ethnicity. Clin Rheumatol 31, 191–192 (2012). https://doi.org/10.1007/s10067-011-1867-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-011-1867-2